Navigation Links
National Jewish, Brigham and Women's Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
Date:10/10/2007

DENVER, Oct. 10 /PRNewswire-USNewswire/ -- Researchers from National Jewish Medical and Research Center and Brigham and Women's Hospital have been awarded a $37 million grant from the National Heart Lung and Blood Institute (NHLBI) to lead the most comprehensive study of chronic obstructive pulmonary disease (COPD) ever undertaken. The multi-institutional study will seek to identify the genetic, epidemiological and radiological characteristics of COPD, with a long-term goal of better understanding the disease and finding more effective treatments.

"COPD is the fourth leading cause of death in the United States, and yet we know so little about the disease," said James Crapo, MD, professor of medicine at National Jewish and co-principal investigator of the study. "This study will help us determine which smokers are most at risk of developing the disease, who is most likely to have progressive disease, and how to more effectively treat it."

"Our goal with this massive project is to discover genes responsible for this chronic lung disease and to develop a comprehensive data sharing plan so that this study will become a national resource for the scientific community," said Edwin Silverman, MD, PhD, associate professor of medicine at BWH and co- principal investigator of the study.

The 16 clinical study centers involved will enroll a total of 10,500 participants, 3,500 of whom will be African American, a population whose COPD rates are rapidly growing and whose risk factors have not been adequately studied.

COPD is an umbrella term for a variety of progressive lung diseases, most commonly emphysema and chronic bronchitis, which damage lung tissue and make it difficult to breathe. Cigarette smoking causes the vast majority of COPD cases, but breathing in other kinds of lung irritants may also cause the disease. A mutation in the alpha-1 antitrypsin gene accounts for about one to

two percent of COPD cases, but researchers hypothesize oth
'/>"/>

SOURCE National Jewish Medical and Research Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, ... interactive music products, today announced that it has ... leading manufacturer and supplier of innovative prosthetic, orthotic ... As part of the agreement, RSL Steeper will ... solution specifically configured for use within UK residential ...
(Date:12/17/2014)...  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... (USPTO) has issued a key patent covering ImmunoCellular,s ... targeting six tumor antigens that are commonly expressed ... 8,871,211, which issued October 28, 2014, include methods ... cell composition comprising peptide epitopes of the six ...
(Date:12/17/2014)... MARLBOROUGH, Mass. , Dec. 17, 2014 /PRNewswire/ ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced completion of enrollment in ... results from the 3-month observations confirmed the 1-month ... year:  Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... 2011 FDA Commissioner Margaret A. Hamburg, M.D., ... can be taken to drive biomedical innovation, while ... http://photos.prnewswire.com/prnh/20090824/FDALOGO) Titled "Driving Biomedical Innovation: Initiatives ... concerns about the sustainability of the medical product ...
... ConvaTec, a world-leading developer and marketer of innovative medical ... Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, has ... the home delivery of stoma and continence care products. ... of England, and as a well-respected company in the home ...
Cached Medicine Technology:FDA Commissioner Outlines Steps to Spur Biomedical Innovation, Improve Health of Americans 2ConvaTec Announces Acquisition of Farnhurst Medical 2
(Date:12/19/2014)... The Hermitage Club at Haystack Mountain, ... Deerfield Valley, announced today that it has unveiled its ... , Three time Grammy Award Winner Kenny Loggins ... by a trail naming ceremony. Hermitage Club Founder, President ... Alright” the theme song for the movie soundtrack to ...
(Date:12/19/2014)... Amy Norton HealthDay Reporter ... moms who were exposed to high levels of air pollution ... autism, a U.S. study suggests. Researchers found that of ... 2002, those exposed to the most air pollution during pregnancy ... developed autism. And exposure during the third trimester, specifically, showed ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 (HealthDay ... at least 20 seconds you may be at risk of ... leg may indicate that small strokes or tiny bleeds have ... is high, the investigators reported online Dec. 18 in the ... on one leg, as well as problems walking, should receive ...
(Date:12/17/2014)... 17, 2014 This prestigious award ... that have made outstanding and innovative contributions to ... progression of private practice physical therapy by the ... Association. , On behalf of Performance Physical Therapy, ... CEO of Performance accepted the award at the ...
(Date:12/17/2014)... No matter how far modern medicine advances, it ... louse parasite—a common childhood malady and a source of ... and twelve million individuals will suffer an infestation. ... comes to the rescue, providing an all-natural treatment that ... record of customer service, and effectiveness in getting rid ...
Breaking Medicine News(10 mins):Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2
... A multi-institutional team of engineers, scientists and clinicians ... biomechanics that could play a role in heart ... ,Patients who have the disease may ... tissue accumulates, blood flow is blocked and tiny ...
... researchers are developing a bioactive paper that can detect ... and viruses, like E-coli, salmonella and SARS. ... active chemicals and can be used in manufacturing products ... salmonella in food, and hospital masks for detecting and ...
... guidelines say daily consumption of fish oil supplements could prevent ... ,New guidelines by the National Institute for Health and ... fatty acids every day to reduce the risk of having ... ,Omega 3 fatty acids are important throughout adult life ...
... and psychological treatments such as hypnotherapy have the potential ... (IBS), say researchers in this weeks BMJ. ... treatments often do not work very well and patients ... or misunderstood. ,Patients with IBS are more ...
... over the past 40 years in England, owing to changes ... finds research published ahead of print in the British Journal ... geographical variation in rates suggest that the NHS is now ... training, say the authors. ,The research team analysed ...
... first human case of avian influenza since 2005, state media ... has officially confirmed that a 29-year-old man has been infected ... case was reported, according to Vietnam News Agency. ... capital Hanoi, began suffering from high fever and breathing difficulties ...
Cached Medicine News:Health News:Research may Yield Improved Treatment for Diseased Lungs 2Health News:Study on Bioactive Paper That can Detect Life Threatening Bacteria and Viruses 2Health News:Hypnotherapy may Help Patients With Irritable Bowel Syndrome 2Health News:NHS Oversupplied With Cataract Surgery, Say Doctors 2
Porous foundation 470 series....
The Opteon stem meets the challenge of providing a high-quality, cost-effective hip implant for the moderate demand patient....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
Medicine Products: